Groupe Belge D'Oncologie Digestive

2 trials 1 recruiting Academic / non-commercial

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

0 Completed trials

1 Countries active

6 Unique IMPs

N/A Results reported

Phase III

Phase II

Phase III: 1 Phase II: 1

Top IMPs

FLUOROURACIL 2 LEVOLEUCOVORIN 2 OXALIPLATIN 2 CAPECITABINE 1 IRINOTECAN 1 LEVOLEUCOVORIN DISODIUM 1

All trials

2 total

BALLAD Belgium - A trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma. The Belgian component of… Pending

2024-518349-85-01 Phase III 1 country CAPECITABINE; FLUOROURACIL; LEVOLEUCOVORIN; OXALIPLATIN
“NALPAC” A NON-COMPARATIVE RANDOMIZED PHASE 2 STUDY, EVALUATING THE EFFICACY OF 5-FU + NALIRI AND 5-FU + NALIRINOX FOR METASTATIC PANCREATIC… Recruiting

2024-516336-97-00 Phase II 1 country FLUOROURACIL; IRINOTECAN; LEVOLEUCOVORIN; LEVOLEUCOVORIN DISODIUM; OXALIPLATIN

Showing 1–2 of 2 trials

← All sponsors A–Z